Search results

• Diversity and inclusion

  In 2021 we defined a D&I roadmap identifying actions, regarding diversity and inclusion, in five key areas.

• Customer driven

  We are listening more closely to our customers than ever before; understanding the things that are of most importance to our customers and how we are performing against them.

• Advancing the efficacy and impact of vaccines

  The acquisition of Biosector in 2018 strengthened our pharmaceutical offering, taking us into the field of vaccine adjuvants.

• Acts of kindness

  The Croda Acts of Kindness programme gave employees the opportunity to nominate local causes and charities to support during COVID-19, with each major site given £10,000.

• Abiotic stress mitigation in onions

  Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.

• Flue2Chem

  In another example of industry-wide collaboration to help tackle the climate emergency, the Flue2Chem Innovate UK project aims to demonstrate that a UK supply chain to produce alkoxylated surfacants from CO2 is economically and technically feasible.

• Digitalisation in manufacturing

  We can see the potential of big data, robotics, analytics and the Internet of Things to drive manufacturing excellence and contribute to our right first time agenda.

• Net zero roadmap for UK manufacturing site

  We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.

• Advocating for Access and Benefit Sharing and biodiversity conservation

  We supported the launch of the third edition of the Brogota Project through the United Nations Biodiversity Conference COP15 side event.

• Improving performance by humanising safety

  Involvement and engagement have increased, and longstanding infrastructure and operational issues are being addressed following a pilot Human Performance Programme at our site in Thane, India.

• Transition to bio-based MPG

  Transitioning our raw materials to bio-based sources will enable us to make a significant positive impact.

• Life cycle assesment

  Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.

• Uni of Cambridge case study

  Working with technology designers NiTech Solutions and The University of Cambridge’s Institute for Manufacturing, we created a new process to manufacture more sustainable surfactants. Traditionally, industrial production of surfactants often occurs in large batch reactors, which have low energy efficiency and a long reaction time.

• Leveraging expertise in UV filters for Asian markets

  There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our sustainability Commitment to be People Positive by 2030.

• Human Performance programme

  Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.

• Reforestation

  Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.

• 1.5°C science-based target validation

  In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.

• Croda Foundation

  We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.

• Collaboration to deliver new vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).

• Responsible business

  /Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image

• Coltide Radiance sustainability in use

  In October we were delighted that our sustainability leadership was recognised as we won Business of the Year at the World Sustainability Awards.

• Waste management

  Iberchem, our global fragrance and flavours business based in Spain, has championed waste management best practices through robust policies and employee education programmes.

• Agroforestry in the Amazon

  The Croda Foundation is supporting an Instituto Amazonas agroforestry project, which aims to revive traditional agriculture practices among indigenous tribes, improving food security and protecting their cultural heritage and environment.

• Improving the customer experience in China

  Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

• Supplying delivery systems to help prevent cardiovascular disease

  Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.

• Supporting the next generation of therapeutic vaccines

  Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

• Bringing anti-ageing benefits to make-up

  Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.

• Sustainability-linked revolving credit facility

  In 2019, we became one of the UK’s first large public companies to include a sustainability metric in a revolving credit facility (RCF), with targets in the seven-year agreement aligned with our 2030 Commitment to become Climate Positive.

• Collaboration to develop alternative vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).

• Investors

  Investor information including financial reporting and events.

• Investor seminar on our Life Sciences sector

  7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Analyst consensus

  Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Industrial Specialties business review

  Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Consumer Care sustainability review

  Connecting sustainability to people, making it personal, is core to the sustainability focus within the Consumer Care business. Consumers desire personal care products that deliver performance, without negatively impacting the planet. Keeping this at the core creates value for our customers’ brands and the consumers they serve.

• Sustainability Progress Statement

  Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.

• Climate Positive

  By 2030, we will be Climate Positive.

• Acquisitions

  Commercialising and increasing our access to new ideas and technologies.

• Regulatory news

  Our most recent announcements to the stock exchange.

• About us

  We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

• EMEA

  Our global headquarters are based in Yorkshire in the UK. We also have a number of offices and manufacturing sites spread across the region.

• USA

  Croda Inc is the North American headquarters for Croda, with over 800 employees, working in a variety of roles in manufacturing, sales, marketing and research and development.

• North America

  Croda Inc is the North American headquarters for Croda, we have four manufacturing sites, four innovation centres and four sales hubs in the region.

• UK Pensions

  Explore information on Croda UK pensions, including state pensions, workplace schemes, death benefits and retirement.

• People Positive

  By 2030, we will be People Positive.

• Life Sciences sustainability review

  Sustainability is embedded in our business strategy, shaping innovation and meeting customer expectations. In Life Sciences, it drives impact, performance and long-term value.

• Chief Executive sustainability statement

  “By thinking boldly, acting with purpose, and living our values every day, we are bringing Smart science to improve lives™ to life and working hard to achieve our commitment to be the most sustainable supplier of innovative ingredients by 2030, delivering solutions to tackle some of the world’s biggest challenges”

• Media coverage Page Summary Title

  Media coverage Page Summary Description